Exosome, an important transmitter in the drug resistance of non-small cell lung cancer
Recent studies have promoted new insights into the biology of non-small cell lung cancer (NSCLC) and made considerable progress in the field of treatment, including targeted therapy for driver gene mutations. Immunotherapy (IO) is another breakthrough, which has achieved amazing clinical efficacy. H...
Saved in:
| Main Authors: | Hongzhi Ji, Li Zhang, Lingyun Ye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1539047/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineered exosomes: a promising design platform for overcoming cancer therapy resistance
by: Peng Zhang, et al.
Published: (2025-08-01) -
Emerging roles of exosomal circRNAs in non-small cell lung cancer
by: Hongyuan Yin, et al.
Published: (2025-04-01) -
Harnessing exosomes for targeted drug delivery systems to combat brain cancer
by: Abdullah E. Basyoni, et al.
Published: (2025-04-01) -
The role of exosomes in bladder cancer immunotherapy
by: Mohammad Mousaei Ghasroldasht, et al.
Published: (2025-06-01) -
Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions
by: Gengqi Liu, et al.
Published: (2025-05-01)